Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29515111
Publication Date : //

CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.


Papillary thyroid carcinoma (PTC) is the one of the most common types of endocrine cancer and has a heterogeneous prognosis. Tumors from patients with poor prognosis may differentially express specific genes. Therefore, an analysis of The Cancer Genome Atlas (TCGA) database was performed and revealed that cytokine receptor-like factor 1 (CRLF1) may be a potential novel target for PTC treatment. The objective of the current study was to explore the expression of CRLF1 in PTC and to investigate the main functions and mechanisms of CRLF1 in PTC. PTC tissues exhibited higher CRLF1 expression at both the mRNA and protein levels than it did with normal thyroid tissues. High CRLF1 levels were associated with aggressive clinicopathological features and poor disease-free survival rates. By using loss-of-function and gain-of-function assays, we found that CRLF1 not only increased cell migration and invasion in vitro but also promoted tumor growth both in vitro and in vivo. In addition, CRLF1 induced epithelial-mesenchymal transitions. Overexpression of CRLF1 activated the ERK1/2 and AKT pathways. The oncogenic effects induced by CRLF1 were suppressed by treating the cells with the MEK inhibitor U0126 or the AKT inhibitor MK-2206. These results suggest that CRLF1 enhances cell proliferation and metastasis in PTC and thus may therefore be a potential therapeutic target for PTC.

Authors : Yu Shi-Tong , Zhong Qian , Chen Ren-Hui , Han Ping , Li Shi-Bing , Zhang Hua , Yuan Li , Xia Tian-Liang , Zeng Mu-Sheng , Huang Xiao-Ming ,

Related products :

Catalog number Product name Quantity
'CC15-01-001 Human Thyroid carcinoma tissue array (Follicular adenocarcinoma papillary carcinoma squamous carcinoma, with normal controls) tissues 7 x 9
'CC15-01-002 Human Thyroid carcinoma tissue array (follicular squamous cell papillary undifferentiated carcinoma with normal thyroid tissue c tissues 7 x 9
HTS-11007 Human Thyroid Tissue Slide (Papillary Carcinoma) (5 slides pk) 1 pk
HTS-11007 Human Thyroid Tissue Slide (Papillary Carcinoma) (5 slides_pk) 1 pk
T16-034-T2 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-009-T1 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-033-T1 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-009-N2 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-009-N1 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-009-T2 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-032-N1 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-010-N1 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-023-T2 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-010-N2 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-010-T1 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-010-T2 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-011-N1 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-007-T2 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-007-T1 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-007-N2 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-033-T2 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-034-N1 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-029-N2 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-001-N1 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg
T16-029-N1 Matched Tumor_ Normal Human Thyroid Tissue Lysates (Papillary carcinoma) 0.1 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur